News

GSK to buy phase III-ready drug efimosfermin from Boston Pharmaceuticals for as much as $2B British pharmaceutical company GSK (GSK) to acquire Boston Pharmaceuticals’ lead asset, efimosfermin alfa, ...
Pan American Silver (NYSE:PAAS) will acquire all of the issued and outstanding common shares of MAG Silver (NYSE:MAG).